Why Revolution Medicines Inc (RVMD) Stock Is Rising
As of 2026-09-28, Revolution Medicines Inc (RVMD) has a next-year EPS growth estimate of 37.81%. Featured in our EPS revision report on 2026-09-28.
Why RVMD Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Revolution Medicines Inc's next-year EPS growth estimate from 38.39% to 38.73% on 2026-09-21.
- ·Current-Year Growth: Projected at -62.73%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 37.81%
- EPS growth this year
- -62.73%
- EPS next quarter (est)
- -$2.40
- Last price
- $201.74
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-28 | 37.81% | -62.73% | -$2.40 | $201.74 |
| 2026-09-27 | 37.81% | -62.73% | -$2.40 | $204.97 |
| 2026-09-25 | 37.81% | -62.73% | -$2.40 | $204.97 |
| 2026-09-24 | 37.81% | -62.73% | -$2.40 | $199.86 |
| 2026-09-23 | 38.73% | -62.57% | -$2.40 | $190.74 |
| 2026-09-22 | 38.73% | -62.57% | -$2.40 | $192.86 |
| 2026-09-21 | 38.73% | -62.57% | -$2.40 | $192.76 |
| 2026-09-20 | 38.39% | -63.29% | -$2.41 | $190.95 |
| 2026-09-18 | 38.39% | -63.29% | -$2.41 | $190.95 |
| 2026-09-17 | 38.39% | -63.29% | -$2.41 | $196.94 |
| 2026-09-16 | 38.39% | -63.29% | -$2.41 | $195.92 |
| 2026-09-15 | 38.39% | -63.28% | -$2.41 | $204.86 |
| 2026-09-14 | 38.39% | -63.28% | -$2.41 | $205.11 |
| 2026-09-13 | 38.39% | -63.28% | -$2.41 | $203.77 |
| 2026-09-11 | 38.39% | -63.28% | -$2.41 | $203.77 |
| 2026-09-10 | 38.39% | -63.28% | -$2.41 | $203.35 |
| 2026-09-09 | 39.59% | -63.16% | -$2.42 | $207.68 |
| 2026-09-08 | 40.51% | -63.05% | -$2.43 | $207.32 |
| 2026-09-07 | 40.51% | -63.05% | -$2.43 | $210.02 |
| 2026-09-06 | 40.92% | -63.39% | -$2.43 | $210.02 |
| 2026-09-04 | 40.92% | -63.39% | -$2.43 | $210.02 |
| 2026-09-03 | 40.92% | -63.39% | -$2.43 | $210.87 |
| 2026-09-02 | 40.92% | -63.39% | -$2.43 | $209.23 |
| 2026-09-01 | 40.92% | -63.39% | -$2.43 | $209.87 |
| 2026-08-31 | 40.92% | -63.39% | -$2.43 | $205.57 |
| 2026-08-30 | 40.16% | -63.82% | -$2.44 | $207.88 |
| 2026-08-29 | 40.16% | -63.82% | -$2.44 | $207.88 |
| 2026-08-28 | 40.16% | -63.82% | -$2.44 | $207.88 |
| 2026-08-27 | 37.87% | -64.14% | -$2.44 | $221.15 |
| 2026-08-26 | 31.19% | -63.49% | -$2.45 | $215.44 |
Reports Featuring RVMD
Recent News
- New pancreatic cancer drug carries a $39,800 monthly list price: What to knowYahoo Personal Finance
- New pancreatic cancer drug carries a $39,800 monthly list price: What to knowYahoo Personal Finance
- Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed IndependentThe Wall Street Journal
- Revolution Medicines $39,800-Monthly Cancer Drug Puts Access In Focus CEO Goldsmith Expects Insurers To Move Swiftly To Provide CoverageStocktwits
- 3 Reasons the AI Stock Boom Is Very Much BackBarrons.com
- Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger betFortune
- Sellas Traders See Pancreatic Cancer Race After RVMDs Drug Approval But Near-Term Focus Remains On SLSs Leukemia PipelineStocktwits
- Sellas Traders See Pancreatic Cancer Race After RVMDs Drug Approval But Near-Term Focus Remains On SLSs Leukemia PipelineStocktwits
- Bloomberg 500 (B500) Index Adds Ten Securities Following September ReconstitutionPR Newswire
- Bloomberg 500 (B500) Index Adds Ten Securities Following September ReconstitutionPR Newswire
Screen Performance
Aggregate stats across all 2055 tickers our top-EPS-revision screen has flagged over the past 180 days.
- Median return since detection
- +0.0%
- % of tickers in the green
- 48%
- Median return on winners
- +23.2%
- Large revisions captured
- 1779
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Revolution Medicines Inc (RVMD) stock go up recently?▾
Revolution Medicines Inc (RVMD) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 38.39% to 38.73% on 2026-09-21. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Revolution Medicines Inc's next-year EPS growth estimate?▾
As of 2026-09-28, Revolution Medicines Inc (RVMD) has a next-year EPS growth estimate of 37.81%, based on analyst consensus.
When was the latest EPS estimate revision for RVMD?▾
The most recent revision occurred on 2026-09-24, when analysts adjusted the next-year EPS growth estimate from 38.73% to 37.81%.
What sector and industry does Revolution Medicines Inc belong to?▾
Revolution Medicines Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RVMD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Revolution Medicines Inc (RVMD) appears here because it was detected by our daily top-EPS-revision-performer screen.